310 related articles for article (PubMed ID: 37784141)
1. Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis.
Zhang F; Cheng T; Zhang SX
Arthritis Res Ther; 2023 Oct; 25(1):187. PubMed ID: 37784141
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
Cejka D; Hayer S; Niederreiter B; Sieghart W; Fuereder T; Zwerina J; Schett G
Arthritis Rheum; 2010 Aug; 62(8):2294-302. PubMed ID: 20506288
[TBL] [Abstract][Full Text] [Related]
3. A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway.
Du H; Zhang X; Zeng Y; Huang X; Chen H; Wang S; Wu J; Li Q; Zhu W; Li H; Liu T; Yu Q; Wu Y; Jie L
Front Immunol; 2019; 10():1620. PubMed ID: 31396207
[TBL] [Abstract][Full Text] [Related]
4. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
[TBL] [Abstract][Full Text] [Related]
5. mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis.
Laragione T; Gulko PS
Mol Med; 2010; 16(9-10):352-8. PubMed ID: 20517583
[TBL] [Abstract][Full Text] [Related]
6. The roles of HDAC with IMPDH and mTOR with JAK as future targets in the treatment of rheumatoid arthritis with combination therapy.
Mane RR; Kale PP
J Complement Integr Med; 2023 Dec; 20(4):689-706. PubMed ID: 36409592
[TBL] [Abstract][Full Text] [Related]
7. Chelerythrine ameliorates rheumatoid arthritis by modulating the AMPK/mTOR/ULK-1 signaling pathway.
Cai J; Zhang LC; Zhao RJ; Pu LM; Chen KY; Nasim AA; Leung EL; Fan XX
Phytomedicine; 2022 Sep; 104():154140. PubMed ID: 35752081
[TBL] [Abstract][Full Text] [Related]
8. Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mammalian target of rapamycin signaling pathway in patients with rheumatoid arthritis.
Tang Y; Bai Z; Qi J; Lu Z; Ahmad ; Wang G; Jin M; Wang B; Chen H; Li X
Clin Exp Immunol; 2021 Dec; 206(3):354-365. PubMed ID: 34558072
[TBL] [Abstract][Full Text] [Related]
9. Effect of moxibustion on autophagy and the inflammatory response of synovial cells in rheumatoid arthritis model rat.
Hao F; Wang Q; Liu L; Wu LB; Cai RL; Sang JJ; Hu J; Wang J; Yu Q; He L; Shen YC; Miao YM; Hu L; Wu ZJ
J Tradit Chin Med; 2022 Feb; 42(1):73-82. PubMed ID: 35294125
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast-like synoviocyte migration is enhanced by IL-17-mediated overexpression of L-type amino acid transporter 1 (LAT1) via the mTOR/4E-BP1 pathway.
Yu Z; Lin W; Rui Z; Jihong P
Amino Acids; 2018 Feb; 50(2):331-340. PubMed ID: 29198077
[TBL] [Abstract][Full Text] [Related]
11. Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis.
Liu S; Ma H; Zhang H; Deng C; Xin P
Clin Immunol; 2021 Sep; 230():108793. PubMed ID: 34242749
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis.
Cheng Q; Chen M; Liu M; Chen X; Zhu L; Xu J; Xue J; Wu H; Du Y
Cell Death Dis; 2022 Jul; 13(7):608. PubMed ID: 35835748
[TBL] [Abstract][Full Text] [Related]
13. The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?
Malemud CJ
Future Med Chem; 2015; 7(9):1137-47. PubMed ID: 26132523
[TBL] [Abstract][Full Text] [Related]
14. Schisandrin treatment suppresses the proliferation, migration, invasion, and inflammatory responses of fibroblast-like synoviocytes from rheumatoid arthritis patients and attenuates synovial inflammation and joint destruction in CIA mice.
Lin W; Liu Y; Zhang S; Xu S; Qiu Q; Wang C; Liu D; Shen C; Xu M; Shi M; Xiao Y; Chen G; Xu H; Liang L
Int Immunopharmacol; 2023 Sep; 122():110502. PubMed ID: 37390648
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives.
Soltani A; Bahreyni A; Boroumand N; Roshan MK; Khazaei M; Ryzhikov M; Soleimanpour S; Avan A; Hassanian SM
J Cell Physiol; 2018 Jun; 233(6):4783-4790. PubMed ID: 29165795
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway.
Li G; Liu Y; Meng F; Xia Z; Wu X; Fang Y; Zhang C; Zhang Y; Liu D
J Cell Mol Med; 2019 Oct; 23(10):7116-7120. PubMed ID: 31411001
[TBL] [Abstract][Full Text] [Related]
17. [Berberine inhibits autophagy and promotes apoptosis of fibroblast-like synovial cells from rheumatoid arthritis patients through the ROS/mTOR signaling pathway].
Zong S; Zhou J; Cai W; Yu Y; Wang Y; Song Y; Cheng J; Li Y; Gao Y; Wu B; Xian H; Wei F
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):552-559. PubMed ID: 37202190
[TBL] [Abstract][Full Text] [Related]
18. The immunobiology of mTOR in autoimmunity.
Suto T; Karonitsch T
J Autoimmun; 2020 Jun; 110():102373. PubMed ID: 31831256
[TBL] [Abstract][Full Text] [Related]
19. Celastrol inhibits rheumatoid arthritis by inducing autophagy via inhibition of the PI3K/AKT/mTOR signaling pathway.
Yang J; Liu J; Li J; Jing M; Zhang L; Sun M; Wang Q; Sun H; Hou G; Wang C; Xin W
Int Immunopharmacol; 2022 Nov; 112():109241. PubMed ID: 36116150
[TBL] [Abstract][Full Text] [Related]
20. Combined therapeutic application of mTOR inhibitor and vitamin D(3) for inflammatory bone destruction of rheumatoid arthritis.
Kim TH; Choi SJ; Lee YH; Song GG; Ji JD
Med Hypotheses; 2012 Dec; 79(6):757-60. PubMed ID: 22967804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
